Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Studies Relying on Brain Scans Are Often Unreliable, Analysis ShowsHow You Can Help Ease the Health Crisis in UkraineAHA News: Bystander CPR on Kids Differs by Race and EthnicityU.S. Airplane, Train and Transit Mask Mandates Extended to April 18Pooch Power: Therapy Dogs Bring Quick Relief in the ERFDA Says Gene-Edited Cattle Are Safe to EatApps: They Help Manage Health Conditions, But Few Use Them, Poll FindsAre Health Care Apps in Your Future?Sackler Family & Purdue Pharma Reach Deal With U.S. States Over Opioid CrisisU.S. Traffic Deaths Rise to Highest Level Since 2007White House Unveils New COVID Response StrategyAlexa Will Soon Put Users in Touch With Telehealth DoctorsJ&J Finalizes $26 Billion Opioid SettlementNearly Half of 500 Million Free COVID Tests Still LeftResearchers Map Out Enormous Human Family TreeCDC Close to New Guidance on COVID RestrictionsWhy Is Cancer-Linked Benzene in So Many Personal Care Products?AHA News: Donating Blood Benefits Both Receiver and Giver – And Now Is a Critical TimeFDA Warns of Rising Dangers of Unapproved Drug TianeptineToo Many Americans Are Getting 'Low-Value' Medical Tests, ProceduresGuns Outpacing Car Crashes as Leading Cause of Trauma Death for AmericansCOVID Travel Rules to Europe May Be Lifted for VaccinatedSackler Family Sweetens Opioid Settlement OfferBrut, Sure Brand Deodorants Under Recall Due to Benzene'Fact Check' Notes Work Best to Counter COVID Lies OnlinePoor Will Be Hit Hardest by a Hotter WorldPandemic Put Brakes on Lifesaving Cancer Research, CareWhen Psychiatric Care Is Far Away, Telehealth Fills the GapFDA Panel Rejects Lilly’s Cancer Drug Tested Only in China1 in 3 People Now Exposed to a Harmful PesticideHow Healthy Is Your State? New Federal Data Ranks EachRed Cross Says Blood Shortage Is Worst in a DecadeBiden Relaunches Cancer Moonshot InitiativeGruesome Warning Images on Soda Labels Could Cut ConsumptionYour Gas Stove Might Make You (and the Planet) SickBiden Administration Withdraws Vaccine Mandate for Large EmployersFree N95 Masks Begin Arriving in U.S. PharmaciesEngland to Lift Travel Restrictions for Vaccinated VisitorsMany Marijuana Vendors Aim Advertising at Kids: StudyConservatorships Keep the Homeless in Psychiatric Wards Too Long: StudyCrowded Emergency Rooms Cost Lives: StudyColonoscopy Surprise Bills Should Be Thing of the Past, Experts SayBiden Plans to Send 400 Million N95 Masks to Americans for FreeWhite House Launches Website for Free Home COVID Tests One Day Ahead of SchedulePolitics Clouds Folks' Views on COVID Rules, Global Survey ConfirmsCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsAmid U.S. Blood Shortage, New Pressure to Ease Donor Rules for Gay MenSupreme Court Blocks Biden's Vaccine Mandate for Large EmployersWhite House May Soon Offer 'High-Quality' Masks to AmericansAmericans Should Avoid Travel to Canada: CDC
Links
Related Topics

Health Insurance
Healthcare

Clinical Trials Are Becoming More Diverse, But There's Still Work To Do

HealthDay News
by Robert Preidt
Updated: Nov 30th 2021

new article illustration

TUESDAY, Nov. 30, 2021 (HealthDay News) -- U.S. cancer clinical trial participants have become more diverse in makeup, but certain groups remain underrepresented, a new study finds.

It's important to have a wide range of participants in clinical trials, to find out if treatments are safe and effective for people with different characteristics, according to the National Cancer Institute (NCI), which has a number of initiatives to boost diversity in clinical trials it funds.

"Our article indicates that the disparity for clinical enrollment in NCI clinical trials has narrowed for minorities, but further efforts are still needed," study author Dr. Juan Javier-DesLoges of UC San Diego Health said in a journal news release.

In this latest study, researchers analyzed 766 NCI-funded breast, colon, lung and prostate cancer trials conducted from 2000 to 2019. Of the nearly 243,000 people in the trials, 81.3% were white, 8.7% were Black, 4.8% were Hispanic and 2.8% were Asian/Pacific Islanders.

When the researchers compared clinical trial participation from 2015 to 2019 with cancer incidence rates from 2015 to 2017, they found that Blacks and Hispanics were more likely to participate in breast cancer clinical trials, but were underrepresented in colon, lung and prostate cancer trials.

People older than 65 were underrepresented in breast, colon and lung cancer trials, and women were underrepresented in colon and lung cancer trials.

When the researchers compared trial participation in 2000–2004 and 2015–2019, they found that Hispanics and Blacks were more likely to be included in recent breast, lung and prostate cancer trials.

While women were less likely to be included in recent colon cancer trials, they were more likely to take part in recent lung cancer trials.

Trends on the inclusion of patients 65 and older varied by cancer type, according to the study published online Nov. 22 in the journal Cancer.

Further work is needed to correct continuing underrepresentation of women and older patients in clinical trials, the researchers noted.

More information

The U.S. National Cancer Institute has more on clinical trials.


SOURCES: Cancer, news release, Nov. 22, 2021




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net